Search

everythinglearnresearchcommunity

for

Search:↓

MK-0773 is a moderate inhibitor of the SRD5A2 enzyme.

Androgenetic alopecia treatments focus on reducing hair loss by targeting hormones, with new therapies showing promise but needing more research.

Accurate diagnosis of rare hyperandrogenism conditions requires detailed testing and sometimes invasive procedures.

Male-pattern hair loss is largely influenced by genetics, with key genes identified.

Understanding how DHT works is important for diagnosing and treating hormone-related disorders.

PCOS is a common hormonal disorder in women, marked by high androgen levels and often seen in 20% of women via ultrasound.

The link between anabolic agents and colorectal cancer risk is unclear.

Polycystic ovary syndrome increases the risk of diabetes, heart disease, and endometrial cancer, and requires early treatment to manage these risks.

Significant progress was made in understanding androgen excess disorders, but much is still unknown.

High levels of male hormones and irregular periods best predict how well PCOS patients will respond to metformin treatment.

Hormonal therapies can improve skin issues by adjusting hormone levels, with future advancements promising better results.

Microglia, the brain's immune cells, may contribute to Polycystic Ovary Syndrome (PCOS) by altering the female brain's structure and function, with kisspeptin neurons and GABA neurotransmitters also playing a role.

New steroid compounds may help with hormonal therapy and have potential benefits for glucose disorders, but more research is needed.

Current treatments for androgenetic alopecia are complex and promising, but more research is needed.

Diagnosing PCOS is challenging due to its complex and varied symptoms.

A woman's rare benign tumor that released both cortisol and testosterone was successfully removed, improving her health.

Protein tyrosine kinases are key in male pattern baldness, affecting skin structure, hair growth, and immune responses.

The document concludes that inflammation markers can be used in diabetes, vitamin D3 affects immune pathways, hyperthyroidism changes hormone levels, androgen levels help diagnose Adrenocortical Carcinoma, erectile dysfunction is linked to diabetes, hypogonadism is common in HIV-infected males, and hormones can be biomarkers for various conditions.

3α-androstanediol helps reduce age-related cognitive and mood declines in male rats, unlike testosterone.

Combining spironolactone with metformin reduces insulin resistance in PCOS better than either drug alone.

Hair steroid profiling is a feasible, non-invasive alternative to serum analysis for assessing hormone levels and metabolism.

Hormone therapy increases the risk of heart-related issues in transgender women and may affect heart health in transgender men.

Many women with PCOS have abnormal cholesterol levels, needing careful management.

PCOS causes infertility mainly due to hormonal imbalances, insulin resistance, and chronic inflammation.

Soy supplements improve various skin conditions and aging signs, with topical use boosting skin barrier function.

Many women who have used performance-enhancing drugs in Finland show high rates of mental health and substance use issues, and most have normal red blood cell counts.

Cocaine impairs male sexual behavior and alters testosterone metabolism in the brain.

About 21% of tested hair loss supplements contained illegal synthetic drugs.

TrichoScan is a reliable method for measuring hair growth and is useful for assessing hair loss treatments.

PCOS may start before birth, involves metabolic issues, and can be treated with drugs like metformin and lifestyle changes.